| 1. | Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening ... Ronco G Giorgi-Rossi P Carozzi F et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical ... |
| 2. | The availability of two vaccines against human papillomavirus raises numerous questions about fine points of cervical cancer prevention IN THIS ARTICLE ... the cause of cervical cancer. Today not only do we know that cause to be persistent human papillomavirus (HPV) ... |
| 3. | Control and Prevention about 20 million people are infected with human papillomavirus (HPV) in the United States. ... 24 Summary Human papillomaviruses are one of the most common STIs and HPV-related disease constitutes a significant health burden worldwide. ... |
| 4. | AS04-adjuvanted HPV-16 and HPV-18 vaccine* is associated with significantly reduced abnormal cytology diagnoses in young women according to research presented ... HPV-16 and HPV-18 vaccine and 9 325 controls who received hepatitis A vaccine at zero one and six months. ... |
| 5. | Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA. 2009;302:750–757. ... Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisor Committee on Immunization Practices ... |
| 6. | Human papillomavirus (HPV) has been shown to be a causative agent in the development of anogenital warts intraepithelial neoplasia and invasive cancers. A quadrivalent HPV vaccine has been approved recently for use in young women ... |
| 7. | rates of low-grade squamous intraepithelial lesions (LSIL) and HPV-positive atypical squamous cells of undetermined significance (ASC-US). ... Ronco G Giorgi-Rossi P Carozzi F et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical ... |
| 8. | 2/3 and VAIN 2/3 related to either HPV 16 or 18. The incidence of VIN 2/3 ... Gissmann L Wolnik L Ikenberg H et al. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas ... |
| 9. | New research has led to a better understanding of human papillomavirus (HPV) epidemiology and vaccination. But how can the clinician incorporate this research into a busy practice? ... |
| 10. | A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical ... vaccine as these misrepresent the nature of VAERS subjects who were anti-HPV 18-seronegative surveillance system.” 56 ... |